Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Open Journal of Cardiology & Heart Diseases

Assessment of Role of Platelet-to-Lymphocyte Ratio in Prediction of Angiographic No-Reflow in Patients Subjected to Primary Percutaneous Coronary Intervention

Submission: January 02, 2020;Published: January 09, 2020

DOI: 10.31031/OJCHD.2020.03.000556

ISSN: 2578-0204
Volume3 Issue2

Abstracts

Primary Percutaneous Intervention is the most advantageous and rewarding reperfusion strategy available in patients with acute ST-segment–elevation myocardial infarction (STEMI), although it fails to restore optimal myocardial reperfusion in a sizeable portion of patients mostly because of no-reflow phenomenon.

No reflow is defined as suboptimal myocardial reperfusion through a part of coronary circulation without angiographic evidence of mechanical vessel obstruction. Inflammation has a substantial role in the initiation and propagation of the atherosclerotic process. The platelet–lymphocyte ratio (PLR) has been recently proposed to be a marker of thrombotic and inflammatory state, mainly in patients with coronary or peripheral ischemic events.

Abbreviations: PPCI: Primary Percutaneous Coronary Intervention; PCI: Percutaneous Coronary Intervention; STEMI: Segment Elevation Myocardial Infarction; PLR: Platelet to Lymphocyte Ratio; TIMI: Thrombolysis in Myocardial Infarction

Get access to the full text of this article